42 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... antimicrobial therapy ... condition #IDSA ... InfectiousDiseases #Pharmacology ... #Management
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
antimicrobial therapy ... #IDSA #Meningitis ... InfectiousDiseases #Pharmacology ... #Management
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive pulmonary ... Aspergillosis #Treatment #management ... #pharmacology # ... IDSA
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Management #Therapy
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
• Combination therapy ... fluoroquinolone #IDSA ... Treatment #Regimen #Management ... #Guidelines #pharmacology
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #medications #pharmacology ... #IDSA #Guidelines
Algorithm for Treatment of Chronic Thromboembolic Disease (CTEPH)
Initial Imaging for Screening - V/Q scan - 90-100%
• Assess for Pulmonary ... Targeted Medical Therapy ... • Balloon Pulmonary ... karanpdesai #cteph #management ... #algorithm #cardiology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... areas Preferred Therapy ... Penicilliosis #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... days) Preferred Therapy ... candida #mucosal #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... /ml Preferred Therapy ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology